Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation

Chinese Medical Journal

Volumn 122, Issue 19, 2009, Pages 2360-2365

  Zhang, Zhi ^a,b   Yu, Bo ^a   Tao, Gui Zhou ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apelin; Apoptosis; Cardiomyocyte; Phosphatidylinositol 3 OH kinase (PI3K) Akt

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APELIN; APELIN 13; CASPASE 3; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE; LIPOCORTIN 5; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; GLUCOSE; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 70350608068     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.19.031     Document Type: Article

References (26)

1. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476. (Pubitemid 28505047)
2. Sorli SC, van den Berghe L, Masri B, Knibiehler B, Audigier Y. Therapeutic potential of interfering with apelin signalling. Drug Discov Today 2006; 11: 1100-1106. (Pubitemid 44792480)
3. Zhang R, Hu C, Wang CR, Ma XJ, Bao YQ, Xu J, et al. Association of apelin genetic variants with type 2 diabetes and related clinical features in Chinese Hans. Chin Med J 2009; 122: 1273-1276.
4. Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 2004; 118: 119-125. (Pubitemid 38296725)
5. Földes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003; 308: 480-485.
6. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538: 162-171. (Pubitemid 32402239)
7. Japp AG, Newby DE. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 2008; 75: 1882-1892.
8. Ronkainen VP, Ronkainen JJ, Hänninen SL, Leskinen H, Ruas JL, Pereira T, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007; 21: 1821-1830. (Pubitemid 46855628)
9. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 2008; 294: H88-H98.
10. Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 2007; 12: 127-138. (Pubitemid 46786647)
11. Jia YX, Pan CS, Zhang J, Geng B, Zhao J, Gerns H, et al. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept 2006; 133: 147-154. (Pubitemid 41820348)
12. Kleinz MJ, Baxter GF. Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regul Pept 2008; 146: 271-277.
13. Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 2008; 10: 725-732.
14. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC, et al. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia reperfusion injury. Basic Res Cardiol 2007; 102: 518-528.
15. Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Guo LJ, et al. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 2007; 12: 247-254. (Pubitemid 46009517)
16. Hedhli N, Pelat M, Depre C. Protein turnover in cardiac cell growth and survival. Cardiovasc Res 2005; 68: 186-196. (Pubitemid 41428415)
17. Yao LL, Wang YG, Cai WJ, Yao T, Zhu YC. Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci 2007; 120: 895-907.
18. Erhardt LR. A review of the current evidence for the use of angiotensin receptor blockers in chronic heart failure. Int J Clin Pract 2005; 59: 571-578. (Pubitemid 41632463)
19. Iwanaga Y, Kihara Y, Takenaka H, Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 2006; 41: 798-806. (Pubitemid 44635562)
20. Mani K. Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Fail Rev 2008; 13: 193-209.
21. Dai T, Ramirez-Correa G, Gao WD. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 2006; 553: 222-228. (Pubitemid 44779594)
22. Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, et al. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 2007; 357: 889-895. (Pubitemid 46711085)
23. Brady AH, Brady NR, Gottlieb RA. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 2006 20; 445-462.
24. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004; 61: 448-460.
25. Nishida K, Yamaguchi O, Otsu K. Crosstalk between autophagy and apoptosis in heart disease. Circ Res 2008; 103: 343-351.
26. Goswami SK, Das DK. Autophagy in the myocardium: dying for survival? Exp Clin Cardiol 2006; 11: 183-188.